A reporter gene assay (RGA) that uses a mouse liver recombinant Hepa1c1c7 containing the firefly luciferase gene was developed to screen for dioxins in human plasma. For a high-sensitivity method, the addition of cycloheximide to the culture medium brought about a fivefold increase in the sensitivity. The detection limit was 0.1 pg/μL/well. Aryl hydrocarbon receptor (AhR) binding affinity factors (AhR-BAF), calculated from the effect concentration 50 (EC50) value, showed approximately the same values as those in WHO-TEF (2006). A significant correlation between RGA and the conventional gas chromatography/mass spectrometry (GC/MS) method was obtained.
Introduction
Investigating human exposure to dioxins is an urgent task that needs to be undertaken by the Japanese government, because deleterious effects of dioxins on human health have been drawing much attention from the general public. Conventionally, high-resolution gas chromatography/mass spectrometry (HRGC/HRMS) is used to measure dioxins in human milk, 1, 2 blood, 3, 4 and food. 5, 6 However, HRGC/HRMS is time-consuming and extremely expensive to perform. Thus, the development of an inexpensive, simple, and highly sensitive method to measure dioxins has been highly demanded by the public and the government. Some methods that may satisfy these requirements are biological methods, such as enzyme-linked immunosorbent assay (ELISA) and reporter gene assay (RGA). We have already reported on the development of ELISA to evaluate dioxin toxicity in human milk 7, 8 and environmental samples. 9 However, it is difficult to determine dioxins in blood by means of conventional ELISA, because the concentration of dioxins in blood is extremely low. An RGA that utilizes a cell line that responds to dioxins via the binding of the dioxins to an aryl hydrocarbon receptor (AhR) on the cell is said to be more sensitive than ELISA. 10 A chemically activated luciferase expression (CALUX) bioassay 10 based on rat hepatoma (H4IIE) cells is a sensitive assay for AhR agonists, such as 2,3,7,8-substituted chlorinated dibenzo-p-dioxins and dibenzofurans and related PCBs. It has been proven to be valuable for the screening of dioxin-like compounds and the assessment of toxic equivalents, because it detects all AhR ligands in a variety of sample matrices. Conventional RGAs, such as CALUX bioassay, have also been used to measure dioxins in blood, [11] [12] [13] milk, 14 food, 15 and environmental samples. 16 However, when the results of some CALUX bioassays were compared with HRGC/HRMS data, no significant correlation was obtained. 11, 13 Moreover, a proportional systematic error was observed 12 in blood analysis. It seems that the responses of AhR-dependent bioassays are dependent on the cell type used and the incubation conditions. In this study, a simple, rapid, and highly sensitive RGA was developed to determine dioxins in plasma.
Experimental
Reagents and chemicals All dioxin standards were from Wellington Laboratories (Canada) and were diluted with decane or dimethyl sulfoxide (DMSO) to appropriate concentrations. Most of the organic solvents, including hexane, acetone, dichloromethane, toluene, diethyl ether, ethanol and methanol (MeOH), were of dioxin analysis grade and were from Kanto Kagaku (Tokyo, Japan) or Wako Pure Chemical Industries (Osaka, Japan). Decane was of special grade and was redistilled prior to use. All other chemicals were of PCB analysis grade or special grade.
A stable recombinant cell line of Hepa1c1c7 (a derivative of the BW7756 mouse hepatoma that arose in a C57/L mouse of the American Type Culture Collection (ATCC, MD, USA)), in which the luciferase reporter gene responded to dioxins was introduced (obtained from Sumitomo Chemical Co. Ltd. (Osaka, Japan)).
Notes
The PicaGene Dual Sea Pansy Luciferase Kit (Toyo Ink, Japan) was used as a cell lysis buffer.
Pretreatment of plasma sample for RGA
A pooled plasma sample was used and the dioxin concentration was confirmed by HRGC/HRMS. The remaining pooled plasma was divided into five portions of 50 g each, and lipid extraction and cleanup procedures were carried out according to an official manual 17 of the Ministry of Health, Labour and Welfare, Japan. After lipid extraction, authentic dioxin standards were added to four of five samples at concentrations of 7.4 -49.6 pg TEQ/g. The remaining sample was used as a control. According to the official Japanese method, 17 the extracted lipid (ca. 0.2 g) was purified by typical procedures, such as alkaline saponification, H2SO4 decomposition, AgNO3/silica gel chromatography and alumina column chromatography. The final cleanup solution was replaced with 20 μL of DMSO.
Cell incubation
The Hepa1c1c7 cell line was incubated at 37 C under 5% (v/v) CO2 and 95% humidified air. Culture "medium A" for a conventional subculture (passage culture) was composed of an α minimal essential medium (αMEM, GIBCO-BRL, USA), 10% (v/v) fetal bovine serum (FBS, GIBCO-BRL), blasticidin S (16 μg/mL medium), and geneticin (800 μg/mL medium). For a dioxin exposure experiment, mixed "medium B" was used, which was composed of αMEM and 10% (v/v) FBS. After reaching approximately 80% confluence, the cells were scraped off a plastic Petri dish (10 cm i.d.; Falcon, #1001; Becton Dickinson) and mixed with medium A. Then, an aliquot of ca. 1/10 of the cell suspension was transferred to a new medium.
Reporter gene assay First day: cell seeding operation. According to the conventional method for cell seeding operation, cells were scraped off plastic Petri dishes, and a cell suspension of ca. 2 × 10 5 cells/mL medium B was prepared. The cell suspension was seeded in each well of a 96-well microplate (COSTER, fluorescence/ luminescence clear-bottomed 96-well plate; Corning Ltd., USA) at 2 × 10 4 cells/100 μL medium/well, and then incubated at 37 C for 24 h. The second day: addition of target compound. (1) Conventional method: Regarding the addition of a target compound in conventional RGA, 10 μL of a sample solution containing dioxins or related compounds dissolved in DMSO was added to 1 mL of culture medium B mixed with the cell suspension described above. Then, 100 μL of the mixture was pipetted into each well of a 96-well microplate, and the cells were incubated at 37 C for another 24 h. Four wells were used for each sample solution and the average value (n = 4) was calculated. The organic solvent concentration in the final solution in each well was kept at 0.5% (v/v).
(2) High sensitivity method: For high-sensitivity RGA, a 500 μg/mL cycloheximide DMSO solution was added at a ratio of 1% (v/v) to culture medium B. The final concentration of cycloheximide was kept at 2.5 μg/mL. The obtained medium was called "medium C." To 0.6 mL of medium C was added 6 μL of a sample solution containing dioxins or related compounds dissolved in DMSO. Then, 100 μL of the mixture was pipetted into each well of a 96-well microplate, and the cells were incubated at 37 C for another 24 h. Four wells were used for each sample solution, and the average value (n = 4) was calculated. The organic solvent concentration in the final solution in each well was kept at 0.5% (v/v). The third day: measurement of luciferase activity. Measurements of the luciferase activity were carried out as follows. After a 24-h exposure of cells to the subject compounds, the medium was pipetted into a microfuge tube and centrifuged. The cells were washed with 100 μL of PBS(-) two times. Subsequently, the cell pellet in each well was extracted with 15 μL/well of a 1/5 diluting solution of cell lysis buffer at ambient temperature for 1 h. Seventy five microliters of a luciferin substrate solution (composed of 20 mM tricine (pH 7.8), 2.67 mM MgSO4, 0.1 mM EDTA, 33.3 mM DTT, 270 μM coenzyme A, 530 μM ATP, and 470 μM luciferin) were pipetted into each well, and the luminescence was determined (delay, 1.6 s; measurement interval, 5 s). The luminescence value of the DMSO solvent was subtracted from the luminescence value of each sample. A positive control (100 pg/μL 2,3,7,8-TCDD for the conventional method, and 4 pg/μL 2,3,7,8-TCDD for the high-sensitivity method) was used to standardize data in each well.
HRGC/HRMS measurement
A HRGC/HRMS measurement of the plasma sample was carried out in accordance with a previously reported method. 2 The toxicity equivalent quantity (TEQ) was calculated using WHO-TEF (2006) values.
Results and Discussion
The dioxin toxicity is mediated by AhR in an animal or a human body. This is supported by an animal experiment that used AhR gene knockout mice. 18 In the RGA discussed herein, the reporter gene of luciferase was introduced under the dioxin responsive element, and the transcription of the luciferase gene was activated according to the concentration of dioxin and the extent of binding to AhR. AhR-activating substances, such as dioxins, were semi-quantified by measuring the luminescence produced by the reaction of luciferase.
Cycloheximide superinduces the transcription of CYP1A1 in the presence of an agonist for the AhR. The mechanism is well known. 19, 20 Briefly, whereas a potent agonist of AhR such as TCDD induces a rapid reduction of the AhR protein, cycloheximide blocks the down-regulation of steady-state AhR. Furthermore, cycloheximide has been shown to increase the accumulation of the TCDD-activated AhR and the functional AhR-Arnt (AhR nuclear translocator) complex in the nucleus. That is, superinduction by cycloheximide is caused by enhancing the stability of agonist-activated AhR. Lusska et al. 19 used cycloheximde for the superinduction of the transcription of CYP1A1, and used bacterial chloramphenicol acetyltransferase (CAT) cDNA as a reporter gene. However, it is known that the CAT assay is less sensitive than the luciferase assay. Therefore, we applied the mechanisms of both superinduction by cycloheximide and luciferase assay to increase the sensitivity of RGA.
Calibration curves by high sensitivity method and conventional method
Calibration curves for 2,3,7,8-TCDD were prepared using high-sensitivity RGA and conventional RGA. In the case of conventional RGA, the linearity was obtained in the range of 0.5 -8.0 pg/μL/well. In contrast, the linearity was obtained in the range of 0.1 -1.0 pg/μL/well in the high-sensitivity RGA proposed in this study. Approximately a fivefold higher sensitivity was achieved with the proposed method using cycloheximide as the enhancer substance, compared to conventional RGA. Using both assays, 2,3,7,8-TCDD over the concentration range of 0.1 -8.0 pg/μL/well was determined. As shown in Table 1 , the AhR binding affinity factors (AhR-BAF) calculated from the EC50 value showed approximately the same values as those in WHO-TEF (2006), although some of the dioxin congeners showed a higher AhR-BAF than those specified in WHO-TEF (2006).
Comparison of RGA and GC/MS method for dioxin measurement of plasma
Although the values determined by RGA were lower (ca. 20 -90%) than those by GC/MS, a fairly good correlation was obtained based on a linear-regression analysis (r = 0.922, n = 5), as shown in Fig. 1 . In this study, lipid basis data were presented but not whole basis data. Because each weight of the extracted lipid was almost the same (mean, 0.243 g; SD, 0.007), it was predicted that whole basis data show the same pattern as the lipid basis pattern. The difference between the two sets of TEQ values might be due to the presence of dioxin-like compounds and other AhR agonists, since not all AhR agonist and antagonist ligands are known. The reason for the low values of RGA is considered to be as follows: loss of dioxins during a sample pretreatment may be responsible for the differences in values obtained by the two methods. In GC/MS, the values were compensated by adding internal standards as a surrogate. Therefore, a recovery experiment should be performed separately and in parallel to a dioxin measurement by RGA.
On the basis of these experiments, we found that the enhancement mechanism of superinduction of CYP1A1 transcription by cycloheximide is effective to the stable recombinant mouse hepatoma cell line, Hepa1c1c7, and the proposed RGA seems to be applicable to the semi-quantification of very small amounts of dioxins in plasma samples. Similar to ELISA, RGA cannot determine individual dioxin congener concentrations. However, RGA can reveal biological effects on the total activation of AhR by various unknown substances in plasma samples. Therefore, data obtained by the proposed RGA are expected to provide much more meaningful toxicological information than data obtained by GC/MS. The proposed RGA can determine the total concentration of all dioxins and dioxin-like compounds. RGA was proven to be a very valuable screening tool by assessing toxic equivalence of dioxins and dioxin-like compounds. The proposed method has an advantage that the sample volume can be decreased to approximately 1/5 compared to a conventional method on account of the higher sensitivity. Fig. 1 Correlation of the dioxin concentration in human plasma determined by GC/MS with those determined by high-sensitivity RGA. 
